COMMUNIQUÉS West-GlobeNewswire

SELLAS Life Sciences Announces Positive Interim Data from Phase 2b NeuVax™ (nelipepimut-S) Clinical Trial in Combination with Herceptin® in HER2 1+/2+ Breast Cancer Patients
02/04/2018
Clinically meaningful activity in favor of investigational nelipepimut-S (NeuVax) + Herceptin arm Clinically and statistically significant efficacy in triple negative breast cancer (TNBC) cohort; p=0.023 NEW YORK, April [...]
Marrone Bio Innovations to Present at The MicroCap Conference in New York on April 9th
02/04/2018
DAVIS, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]
Progenics Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference
02/04/2018
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, [...]
First Choice Healthcare Solutions to Report Fourth Quarter and Full Year 2017 Results and Update on Strategic Partnership with Steward Health Care on April 3, 2018
02/04/2018
MELBOURNE, Fla., April 02, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
02/04/2018
PHOENIX, April 02, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Patients
02/04/2018
SOUTH SAN FRANCISCO, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
Align Technology to Announce First Quarter 2018 Results on April 25, 2018
02/04/2018
SAN JOSE, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN ) announced today that the Company will report first quarter 2018 financial results on Wednesday, April 25, 2018 after the close [...]
Ascendis Pharma A/S Appoints Thomas A. Larson as Chief Commercial Officer
02/04/2018
COPENHAGEN, Denmark, April 02, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a clinical stage biopharmaceutical company that applies its innovative TransCon technology to address significant unmet [...]
Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
02/04/2018
DURHAM, NC, April 02, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]
Interpace Diagnostics Announces Coverage of Its Thyroid Assays by Blue Shield of California
02/04/2018
PARSIPPANY, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]
Hemispherx Biopharma Announced Financial Results for the Year Ended December 31, 2017
02/04/2018
ORLANDO, Fla., April 02, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on immuno-pharmaceutical research and the commercial development of its immunology products Ampligen® and Alferon [...]
ViaDerma, Inc. Provides an Update of Current and Future Product Sales
02/04/2018
LOS ANGELES, April 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide a update on current sales of the Company’s flagship product, Vitastem. ViaDerma launches Wound Care [...]
Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer
02/04/2018
Company strengthens management team with biopharmaceutical veteran bringing extensive commercial experience in life-threatening rare diseases Tim Miller, Ph.D. continues as president and assumes chief scientific officer [...]
Albireo to Present at H.C. Wainwright Global Life Sciences Conference
02/04/2018
BOSTON, April 02, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
Chimerix to Present at the H.C. Wainwright Annual Global Life Sciences Conference
02/04/2018
DURHAM, N.C., April 02, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that Garrett [...]
XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
02/04/2018
AUSTIN, Texas, April 02, 2018 (GLOBE NEWSWIRE) -- XBiotech USA, Inc. (NASDAQ: XBIT ) announced today that it has obtained an exclusive, worldwide license from CT Atlantic AG (CTA), a Swiss biotechnology company. Under [...]
Women In Bio Closes Boardroom Ready 2018 Applications and Celebrates Board Appointments of Program Alumni
02/04/2018
NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Women In Bio (WIB), an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences, has closed the [...]
Idera Pharmaceuticals Files Definitive Proxy Statement in Connection with Pending Merger with BioCryst Pharmaceuticals
02/04/2018
EXTON, Pa., April 02, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ) (“Idera”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel [...]
Rhythm Pharmaceuticals Announces Licensing Agreement with Takeda for the Development and Commercialization of Preclinical Treatment for Prader-Willi Syndrome
02/04/2018
-- Oral Ghrelin O-Acyltransferase (GOAT) Inhibitor Complements and Expands Efforts in Prader-Willi Syndrome -- -- In Preclinical Models, Prevented Body Weight Gain and Reduced Fat Mass -- -- Rhythm Expects to File [...]

Pages